Cargando…
Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Most patients with HCC have advanced disease at initial diagnosis, and sorafenib has been the only systemic treatment option for more than a decade in patients with advanced, unresectable HCC. However,...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719284/ https://www.ncbi.nlm.nih.gov/pubmed/36471742 http://dx.doi.org/10.2147/JHC.S365002 |